查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1258154

个性化医疗副产品（个性化医疗诊断、个性化医疗、个性化医疗、个性化营养/健康）全球市场规模的研究和预测，按地区分析，2022-2029

Global Personalized Medicine Market Size study & Forecast, by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球个性化医疗市场价值约为 5143.3 亿美元，预计在 2022-2029 年预测期内将以超过 6.95% 的健康增长率增长。我来了。

个性化医疗，也称为精准医疗，将人分成不同的组，并根据患者的预期反应和疾病风险为每个患者量身定制医疗决策、治疗、实践和/或产品。它适用于 这个市场在很大程度上是由对新药开发的需求不断增长、癌症患者和其他疾病数量的增加所推动的。 此外，越来越多的临床试验推动了 2022-2029 年预测期内的市场增长。 此外，主要市场参与者的参与度增加也为这一时期的市场带来了有利可图的增长机会。

此外，预计罕见病的流行将加速市场的扩张。 由于我们对人类基因组特征的理解和关联的进步，许多个性化医疗和治疗活动的发展成为可能。 例如，2022 年 9 月在加州大学尔湾分校进行的一项研究揭示了一种通过应用高度个性化和精确的基因组编辑来治疗遗传性视网膜疾病 (IRD) 的独特方法。 与此同时，FDA 批准的伴随诊断的数量也在增加。 例如，2020年10月，罗氏获得美国FDA批准扩大使用cobas EGFR Mutation Test治疗非小细胞肺癌。 然而，个性化医疗的高成本阻碍了整个 2022-2029 年预测期内的市场增长。

全球个性化医疗市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和拉丁美洲其他地区。 2021年，北美将占据最大份额。 这导致了大型製药公司和研究机构的资助。 各种疾病现在最好用个性化药物治疗，因此针对每种情况的药物发现和研究现在都包括个性化药物。 用于诊断的个性化医疗正在该地区取得进展。 亚太地区对个性化诊断和新疗法的需求正在增长，以应对日益流行的疾病，预计在预测期内增长最快。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家行业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的潜在微观市场机会，以及对主要参与者的竞争格局和产品供应的深入分析。 .

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 个性化医疗市场，按地区划分，2019-2029 年
    • 个性化医疗市场，副产品，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球个性化医疗市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章全球个性化医疗市场动态

  • 个性化医疗市场影响分析（2019-2029 年）
    • 市场驱动力
      • 罕见病患病率
      • 越来越多的临床试验
      • 对新药发现的需求不断增长
    • 市场挑战
      • 个性化医疗的高成本
    • 市场机会
      • 主要市场参与者的主动性不断提高

第四章全球个性化医疗市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 主要投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球个性化医疗市场：按产品分类

  • 市场概况
  • 全球个性化医疗市场：按产品分类的性能潜力分析
  • 2019-2029 年全球个性化医疗市场按产品估算和预测
  • 个性化医疗市场、细分市场分析
    • 个性化医疗诊断
    • 个性化医疗
    • 个性化医疗
    • 个性化营养和健康

第 7 章。全球个性化医疗市场：区域分析

  • 个性化医疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按产品估算和预测
    • 加拿大
  • 欧洲个性化医疗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太个性化医疗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲个性化医疗市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 8 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 通用电气医疗
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概览
      • 近期趋势
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Abbott
    • Dako A/S
    • Exact Sciences Corporation
    • Danaher Corporation（Cepheid, Inc.）
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.

第九章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Personalized Medicine Market is valued approximately USD 514.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.95% over the forecast period 2022-2029. Personalised medicine, is also known as precision medicine, it divides people into distinct groups and then tailors medical decisions, therapies, practises, and/or products to each patient depending on that patient's expected response or illness risk. The market is majorly driven by rising demand for novel drug discovery, rising number of cancer cases and other diseases. Along with this, growing number of clinical trials is driving the growth for the market over the forecast period 2022-2029. Moreover, rising initiatives by key market players is creating lucrative growth opportunity for the market over the period.

It is also projected that the rising prevalence of rare diseases will accelerate market expansion. The development of numerous individualized medical treatments and therapeutic activities has been made possible by advances in our understanding and correlation of the properties of the human genome. For instance, a research study conducted at the University of California, Irvine in September 2022 offered a unique method for treating inherited retinal diseases (IRDs) by applying precise genome editing that is highly tailored to the needs of an individual. Along with this, there are an increasing number of companion diagnostics that have received FDA approval. For example, Roche received U.S. FDA clearance in October 2020 to expand the use of the Cobas EGFR Mutation Test for the treatment of non-small cell lung cancer. However, the high cost of Personalized Medicine stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Personalized Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America had the largest share. This is linked to funding from large pharmaceutical companies and research organisations. All types of ailments are now best treated with personalised medicine, which is why drug discovery and research into any condition now include it. In the region, personalised medicine is advancing for diagnostic purposes. Due to rising demand for personalised diagnostics and novel treatment medications to combat the region's rising disease prevalence, Asia Pacific is anticipated to have the fastest expanding segment over the course of the projection year.

Major market players included in this report are:

  • GE Healthcare
  • Illumina, Inc.
  • ASURAGEN, INC.
  • Abbott
  • Dako A/S
  • Exact Sciences Corporation
  • Danaher Corporation (Cepheid, Inc.)
  • Decode Genetics, Inc.
  • QIAGEN
  • Exagen Inc.

Recent Developments in the Market:

  • In order to create personalised nutrition for healthcare providers and their subjects using a high-end technology interface, Panaceutics Nutrition and Viocare announced a collaborative agreement in January 2022. This agreement will combine Viocare's nutrition assessment software with personalised nutrition supplementation to create an end-to-end service platform.
  • Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany joined up in February 2022 to apply precision medicine in healthcare in strategic, structural, and content-specific ways.

Global Personalized Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Personalized Medicine Diagnostics
  • Personalized Medicine Therapeutics
  • Personalized Medical Care
  • Personalized Nutrition & Wellness

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Personalized Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Personalized Medicine Market, by Product, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Personalized Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Personalized Medicine Market Dynamics

  • 3.1. Personalized Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of rare disease
      • 3.1.1.2. Growing number of clinical trials
      • 3.1.1.3. Rising demand for novel drug discovery
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Personalized Medicine
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising initiatives by key market players

Chapter 4. Global Personalized Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Personalized Medicine Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Personalized Medicine Market by Product, Performance - Potential Analysis
  • 6.3. Global Personalized Medicine Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Personalized Medicine Market, Sub Segment Analysis
    • 6.4.1. Personalized Medicine Diagnostics
    • 6.4.2. Personalized Medicine Therapeutics
    • 6.4.3. Personalized Medical Care
    • 6.4.4. Personalized Nutrition & Wellness

Chapter 7. Global Personalized Medicine Market, Regional Analysis

  • 7.1. Personalized Medicine Market, Regional Market Snapshot
  • 7.2. North America Personalized Medicine Market
    • 7.2.1. U.S. Personalized Medicine Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Personalized Medicine Market
  • 7.3. Europe Personalized Medicine Market Snapshot
    • 7.3.1. U.K. Personalized Medicine Market
    • 7.3.2. Germany Personalized Medicine Market
    • 7.3.3. France Personalized Medicine Market
    • 7.3.4. Spain Personalized Medicine Market
    • 7.3.5. Italy Personalized Medicine Market
    • 7.3.6. Rest of Europe Personalized Medicine Market
  • 7.4. Asia-Pacific Personalized Medicine Market Snapshot
    • 7.4.1. China Personalized Medicine Market
    • 7.4.2. India Personalized Medicine Market
    • 7.4.3. Japan Personalized Medicine Market
    • 7.4.4. Australia Personalized Medicine Market
    • 7.4.5. South Korea Personalized Medicine Market
    • 7.4.6. Rest of Asia Pacific Personalized Medicine Market
  • 7.5. Latin America Personalized Medicine Market Snapshot
    • 7.5.1. Brazil Personalized Medicine Market
    • 7.5.2. Mexico Personalized Medicine Market
  • 7.6. Rest of The World Personalized Medicine Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. GE Healthcare
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Illumina, Inc.
    • 8.2.3. ASURAGEN, INC.
    • 8.2.4. Abbott
    • 8.2.5. Dako A/S
    • 8.2.6. Exact Sciences Corporation
    • 8.2.7. Danaher Corporation (Cepheid, Inc.)
    • 8.2.8. Decode Genetics, Inc.
    • 8.2.9. QIAGEN
    • 8.2.10. Exagen Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Personalized Medicine Market, report scope
  • TABLE 2. Global Personalized Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Personalized Medicine Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Personalized Medicine Market
  • TABLE 69. List of primary sources, used in the study of global Personalized Medicine Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Personalized Medicine Market, research methodology
  • FIG 2. Global Personalized Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Personalized Medicine Market, key trends 2021
  • FIG 5. Global Personalized Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Personalized Medicine Market, porters 5 force model
  • FIG 7. Global Personalized Medicine Market, pest analysis
  • FIG 8. Global Personalized Medicine Market, value chain analysis
  • FIG 9. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Personalized Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Personalized Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable